The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose

出版年份 2021 全文链接

  1. 首页
  2. 学术论文
  3. 论文搜索
  4. 论文详情
标题
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose
作者
关键词
-
出版物
ANNALS OF INTERNAL MEDICINE
Volume 174, Issue 2, Pages JC15
出版商
American College of Physicians
发表日期
2021-02-02
DOI
10.7326/acpj202102160-015

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
研讨会 海报 问题 讨论圈 基金 学术期刊 论文评议 科研社交 资讯集成 审稿人 关于我们 常见问题 移动App 隐私条款 使用条款
© Peeref 2019-2024. All rights reserved.